CIK 0001678660 · Non-accelerated filer<br>Smaller reporting company
Prelude Therapeutics Inc
Sign in to watch- Ticker
- PRLD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811384762
- Phone
- (302) 467-1280
- Business address
- 175 INNOVATION BOULEVARD, WILMINGTON, DE, 19805
- Former names
- Prelude Therapeutics Inc.
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes President, CMO gave up 3,355 shares (to pay taxes)
- 4 Shares withheld for taxes President, CMO gave up 3,355 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes President, CMO gave up 3,355 shares (to pay taxes)
- 4 Open-market buy Chief Chemistry Officer bought 100,000 shares at $0.69 ($69,250)
- 4 Open-market buy CEO bought 675,000 shares at $0.69 ($467,438)
- 4 Open-market buy CEO bought 20,416 shares at an average $0.73 ($14,909)
- 4 Open-market buy CEO bought 39,105 shares at an average $0.75 ($29,460)
- 4 Open-market buy CEO bought 97,500 shares at an average $0.71 ($69,564)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 10 · 185 filings